New Prostate Cancer Screening Guidelines Recommend Routine PSA Testing
New guidelines recommend routine biennial PSA screening for average-risk men aged 50–69, with earlier and more frequent testing for high-risk groups to…

Updated clinical guidelines now recommend routine prostate-specific antigen (PSA) screening for men aged 50 to 69 at average risk, with testing intervals set at two years. This policy shift marks a departure from previous guidance, which favored shared decision-making over universal screening recommendations. The updated framework aims to balance early detection of aggressive malignancies with the mitigation of overdiagnosis and overtreatment risks.
High-risk populations, including Black men and those with specific family histories, are advised to initiate annual screening at age 45. For men aged 70 to 74, the decision to continue screening is subject to individual clinical consultation, while routine screening is generally not recommended for individuals aged 75 and older.
United States
The updated protocol introduces diagnostic guardrails to manage potential harms. If initial PSA levels exceed established thresholds—3 ng/mL for men under 70 and 6.5 ng/mL for those 70 and older—repeat testing is required before further intervention. Subsequent diagnostic steps prioritize non-invasive methods, such as prostate MRI or biomarker testing, reserving biopsies for cases with high clinical suspicion.
These recommendations are intended to address the high
For patients diagnosed with low-risk prostate cancer, the guidelines emphasize active surveillance as the primary management strategy to avoid unnecessary medical procedures. These recommendations are intended to address the high incidence of prostate cancer, which remains the second leading cause of cancer-related mortality among men in the United States. Approximately 334,000 new diagnoses and 36,320 deaths are projected for 2026.
These updated standards arrive as federal health authorities undergo significant leadership transitions and internal restructuring. The alignment or divergence of these new guidelines with future federal preventive care recommendations remains a point of interest for healthcare providers and policy stakeholders, particularly given ongoing debates regarding the composition and influence of federal health advisory panels.
More stories
- Dietitians advise small swaps for plant-based eating
- TikTok dementia videos mislead in 66.4% of sample, researchers say
- Aberdeen Royal Infirmary faces police inquiry call over 19 deaths
- Bariatric surgery group loses 28.2% after GLP-1 use
- TOFA boosts mouse energy use 18% while preserving muscle
- ICO probes NHS therapy notes accessible to up to 140,000 staff
- NIH-funded researchers map basal ganglia at single-cell resolution
- PFOS levels track 93% higher aggressive breast cancer rate
- Plant-based dairy swaps may lower iodine intake
- Adults 50 to 64 reach 7.5% heavy-drinking rate
Latest news
- David Parr House to honor Victorian art-workman with blue plaque
- Iran's attacks hit 25 tankers near Strait of Hormuz
- FCC approves prison cellphone jamming despite 2.5-mile warning
- Russia strikes Ukraine as Odesa faces electricity strain
- Bahrain reports two injuries after Iranian aerial attacks
- Congress tests Black Democrats' growing policy influence
- Baltic responders fight Sparta II fire after drone strike
- Europe faces attribution gap after 16 cyber, physical incidents

